Live Chat

The FDA, Actos, and You

The Food and Drug Administration (FDA) issued an opinion within the last twelve months starkly outlining one of the principle risks of Actos (pioglitazone): the threat of bladder cancer. Specifically, for patients who take Actos longer than twelve months, the likelihood of developing bladder cancer increases appreciably.


What should you do? Beware of the signs and symptoms of illness. If you’ve experienced symptoms such as lower back or abdominal pain, discolored urine, or an urgent need to urinate, you may face a serious threat to your health. If you take Actos and, in particular, if you’ve experienced symptoms like these, you should contact your health care provider.

You should also consider speaking with the attorneys and professionals at Fears Nachawati, too. With years of experience and dedicated expertise, we may be able to provide you with the help you need. Talk to us today. For a free consultation, call us at 1.866.545.8364 or email We’re ready to fight for you!

Drug Litigation

The FDA, Actos, and You